FDA Action On MDMA Gives New Hope To Researchers And Victims Of PTSD
For the first time ever, with the recent FDA approval, psychedelic-assisted psychotherapy will be evaluated in Phase 3 trials for possible prescription use, with MDMA-assisted psychotherapy for PTSD leading the way.
Copy and paste this URL into your WordPress site to embed
Copy and paste this code into your site to embed